Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Clinical trial NCT00078338 · COMPLETED

Trial details

NCT number: NCT00078338
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2004-02-16
Primary completion: 2006-11-28
Enrollment: 764

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.